VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $23,074,345,000 | -22.1% | 129,355 | -3.0% | 5.53% | -10.2% |
| Q2 2015 | $29,619,259,000 | +6.4% | 133,330 | -4.9% | 6.16% | +5.5% |
| Q1 2015 | $27,848,510,000 | +39.6% | 140,210 | +0.6% | 5.83% | +33.6% |
| Q4 2014 | $19,946,672,000 | +8.6% | 139,380 | -0.4% | 4.37% | +7.9% |
| Q3 2014 | $18,368,656,000 | +14.2% | 140,005 | +9.8% | 4.05% | +17.0% |
| Q2 2014 | $16,087,237,000 | +12.7% | 127,555 | +17.8% | 3.46% | +8.6% |
| Q1 2014 | $14,270,597,000 | +19.4% | 108,250 | +6.4% | 3.19% | +18.9% |
| Q4 2013 | $11,948,385,000 | +58.8% | 101,775 | +41.1% | 2.68% | +42.7% |
| Q3 2013 | $7,524,801,000 | +24.2% | 72,125 | +2.5% | 1.88% | +19.3% |
| Q2 2013 | $6,060,032,000 | – | 70,400 | – | 1.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |